Sign in

CIK 0001637715

  • Emerging growth company

OnKure Therapeutics, Inc.

Sign in to watch
Ticker
OKUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472309515
Phone
+1 720-307-2892
Business address
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
Former names
Reneo Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,157
in 2 filings

Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-21 Saccomano Nicholas A President and CEO Sale −87 $2.97 $259 11,160
2026-08-07 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +150,000 150,000
2026-08-07 Saccomano Nicholas A President and CEO Returned to the company · Employee Stock Option (right to buy) −2,359 0
2026-08-07 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +2,359 2,359
2026-08-07 Saccomano Nicholas A President and CEO Returned to the company · Employee Stock Option (right to buy) −1,485 0
2026-08-07 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +1,485 1,485
2026-08-07 Saccomano Nicholas A President and CEO Returned to the company · Employee Stock Option (right to buy) −8,449 0
2026-08-07 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +8,449 8,449
2026-08-07 Saccomano Nicholas A President and CEO Returned to the company · Employee Stock Option (right to buy) −16,898 0
2026-08-07 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +16,898 16,898
2026-08-07 Saccomano Nicholas A President and CEO Returned to the company · Employee Stock Option (right to buy) −542,232 0
2026-08-07 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +542,232 542,232
2026-06-22 Saccomano Nicholas A President and CEO Sale −86 $4.40 $378 11,247
2026-04-01 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +330,000 330,000
2026-03-23 Saccomano Nicholas A President and CEO Sale −86 $4.16 $357 7,333
2025-12-22 Saccomano Nicholas A President and CEO Sale −87 $2.97 $258 7,419
2025-09-22 Saccomano Nicholas A President and CEO Sale −88 $2.62 $231 3,506
2025-06-23 Saccomano Nicholas A President and CEO Sale −88 $2.38 $210 3,594
2025-04-07 Saccomano Nicholas A President and CEO Sale −516 $2.67 $1K 3,682
2025-04-04 Saccomano Nicholas A President and CEO Sale −358 $3.33 $1K 4,198

Page 1 of 2 · 27 trades